Related Experiment Video
Updated: Jan 19, 2026

04:08
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
3.3K
Speeding Up Gait in Parkinson's Disease
Daniel S Peterson1,2,3, Martina Mancini4, Peter C Fino5
1College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
Journal of Parkinson'S Disease
|September 29, 2019
Summary
In people with Parkinson's disease (PwPD), faster walking speeds alter stride length and cadence but not turning or stability. Even at similar speeds, PwPD show gait differences compared to neurotypical adults.
Area of Science:
- Neuroscience
- Biomechanics
- Movement Science
Background:
- Gait speed is a key indicator of mobility, function, and mortality, often affected in people with Parkinson's disease (PwPD).
- Changes in gait speed alone may not fully capture the complex alterations in gait characteristics experienced by PwPD.
Purpose of the Study:
- To identify which gait outcomes change concurrently with walking speed in PwPD.
- To guide the selection of appropriate outcome measures for assessing and monitoring gait performance in this population.
Main Methods:
- 67 PwPD and 40 neurotypical adults performed 2-minute overground walks at comfortable and fast speeds.
- Inertial sensors captured detailed gait and turning parameters.
- A subset analysis compared PwPD walking fast to neurotypical adults walking comfortably to control for gait speed.
Main Results:
- Fast walking significantly altered stride length, cadence, and stride time variability in PwPD, but not steps to turn, trunk range of motion, or stability.
- PwPD demonstrated altered turning, lumbar stability, and stride length/cadence even when walking at speeds comparable to neurotypical adults.
Conclusions:
- Gait speed is crucial for mobility assessment, but in PwPD, other gait parameters remain affected independently of speed.
- Careful selection of outcome measures is essential to comprehensively evaluate the diverse gait abnormalities in PwPD.
Related Concept Videos
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment
995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995

